| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | TUBB3 TUBB4A TUBB4B GSPT2 ABCA13 TUBB SMC4 DHX32 TUBB2B SRCAP RFC5 ATP2B3 TUBB2A OPA1 RAD50 | 2.67e-07 | 775 | 78 | 15 | GO:0017111 |
| GeneOntologyMolecularFunction | pyrophosphatase activity | TUBB3 TUBB4A TUBB4B GSPT2 ABCA13 TUBB SMC4 DHX32 TUBB2B SRCAP RFC5 ATP2B3 TUBB2A OPA1 RAD50 | 7.30e-07 | 839 | 78 | 15 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | TUBB3 TUBB4A TUBB4B GSPT2 ABCA13 TUBB SMC4 DHX32 TUBB2B SRCAP RFC5 ATP2B3 TUBB2A OPA1 RAD50 | 7.41e-07 | 840 | 78 | 15 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | TUBB3 TUBB4A TUBB4B GSPT2 ABCA13 TUBB SMC4 DHX32 TUBB2B SRCAP RFC5 ATP2B3 TUBB2A OPA1 RAD50 | 7.41e-07 | 840 | 78 | 15 | GO:0016818 |
| GeneOntologyMolecularFunction | structural constituent of cytoskeleton | 1.19e-05 | 130 | 78 | 6 | GO:0005200 | |
| GeneOntologyMolecularFunction | (R)-limonene 6-monooxygenase activity | 1.51e-05 | 2 | 78 | 2 | GO:0052741 | |
| GeneOntologyMolecularFunction | limonene monooxygenase activity | 1.51e-05 | 2 | 78 | 2 | GO:0019113 | |
| GeneOntologyMolecularFunction | (S)-limonene 6-monooxygenase activity | 1.51e-05 | 2 | 78 | 2 | GO:0018675 | |
| GeneOntologyMolecularFunction | (S)-limonene 7-monooxygenase activity | 1.51e-05 | 2 | 78 | 2 | GO:0018676 | |
| GeneOntologyMolecularFunction | GTPase activity | 5.53e-05 | 341 | 78 | 8 | GO:0003924 | |
| GeneOntologyMolecularFunction | linoleic acid epoxygenase activity | 8.99e-05 | 4 | 78 | 2 | GO:0071614 | |
| GeneOntologyMolecularFunction | arachidonate 11,12-epoxygenase activity | 8.99e-05 | 4 | 78 | 2 | GO:0008405 | |
| GeneOntologyMolecularFunction | arachidonate epoxygenase activity | 1.09e-04 | 24 | 78 | 3 | GO:0008392 | |
| GeneOntologyMolecularFunction | fatty acid omega-1 hydroxylase activity | 1.49e-04 | 5 | 78 | 2 | GO:0120502 | |
| GeneOntologyMolecularFunction | long-chain fatty acid omega-1 hydroxylase activity | 1.49e-04 | 5 | 78 | 2 | GO:0120319 | |
| GeneOntologyMolecularFunction | arachidonate 14,15-epoxygenase activity | 1.49e-04 | 5 | 78 | 2 | GO:0008404 | |
| GeneOntologyMolecularFunction | arachidonate monooxygenase activity | 1.57e-04 | 27 | 78 | 3 | GO:0008391 | |
| GeneOntologyMolecularFunction | GTP binding | 1.58e-04 | 397 | 78 | 8 | GO:0005525 | |
| GeneOntologyMolecularFunction | guanyl ribonucleotide binding | 3.13e-04 | 439 | 78 | 8 | GO:0032561 | |
| GeneOntologyMolecularFunction | guanyl nucleotide binding | 3.13e-04 | 439 | 78 | 8 | GO:0019001 | |
| GeneOntologyMolecularFunction | steroid hydroxylase activity | 3.14e-04 | 34 | 78 | 3 | GO:0008395 | |
| GeneOntologyMolecularFunction | aromatase activity | 3.43e-04 | 35 | 78 | 3 | GO:0070330 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor | 4.15e-04 | 8 | 78 | 2 | GO:0033695 | |
| GeneOntologyMolecularFunction | caffeine oxidase activity | 4.15e-04 | 8 | 78 | 2 | GO:0034875 | |
| GeneOntologyMolecularFunction | estrogen 16-alpha-hydroxylase activity | 8.10e-04 | 11 | 78 | 2 | GO:0101020 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen | 9.28e-04 | 49 | 78 | 3 | GO:0016712 | |
| GeneOntologyMolecularFunction | cardiolipin binding | 1.33e-03 | 14 | 78 | 2 | GO:1901612 | |
| GeneOntologyMolecularFunction | retinoic acid 4-hydroxylase activity | 1.33e-03 | 14 | 78 | 2 | GO:0008401 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on CH or CH2 groups | 1.53e-03 | 15 | 78 | 2 | GO:0016725 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 1.68e-03 | 441 | 78 | 7 | GO:0016887 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | PDPN CACNA2D4 ABCA13 SV2A KCNQ4 KCNJ3 CACNA1I SLC5A8 SLC25A25 ATP2B3 DISP1 SLC2A11 | 2.00e-03 | 1180 | 78 | 12 | GO:0022857 |
| GeneOntologyMolecularFunction | phosphatidylglycerol binding | 2.21e-03 | 18 | 78 | 2 | GO:1901611 | |
| GeneOntologyMolecularFunction | GTPase activating protein binding | 2.47e-03 | 19 | 78 | 2 | GO:0032794 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic cation channel activity | 2.97e-03 | 152 | 78 | 4 | GO:0022843 | |
| GeneOntologyMolecularFunction | helicase activity | 3.42e-03 | 158 | 78 | 4 | GO:0004386 | |
| GeneOntologyMolecularFunction | transporter activity | PDPN CACNA2D4 ABCA13 SV2A KCNQ4 KCNJ3 CACNA1I SLC5A8 SLC25A25 ATP2B3 DISP1 SLC2A11 | 4.11e-03 | 1289 | 78 | 12 | GO:0005215 |
| GeneOntologyMolecularFunction | protein kinase A regulatory subunit binding | 4.26e-03 | 25 | 78 | 2 | GO:0034237 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 5.64e-03 | 182 | 78 | 4 | GO:0005244 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 5.86e-03 | 184 | 78 | 4 | GO:0022832 | |
| GeneOntologyBiologicalProcess | cell fate specification | 6.67e-06 | 123 | 77 | 6 | GO:0001708 | |
| GeneOntologyBiologicalProcess | determination of left/right symmetry | 2.41e-05 | 154 | 77 | 6 | GO:0007368 | |
| GeneOntologyBiologicalProcess | left/right pattern formation | 3.20e-05 | 162 | 77 | 6 | GO:0060972 | |
| GeneOntologyBiologicalProcess | determination of bilateral symmetry | 3.55e-05 | 165 | 77 | 6 | GO:0009855 | |
| GeneOntologyBiologicalProcess | specification of symmetry | 3.55e-05 | 165 | 77 | 6 | GO:0009799 | |
| GeneOntologyBiologicalProcess | cell fate commitment | 3.77e-05 | 338 | 77 | 8 | GO:0045165 | |
| GeneOntologyBiologicalProcess | Golgi to endosome transport | 3.92e-05 | 18 | 77 | 3 | GO:0006895 | |
| GeneOntologyBiologicalProcess | epoxygenase P450 pathway | 7.32e-05 | 22 | 77 | 3 | GO:0019373 | |
| GeneOntologyBiologicalProcess | outflow tract septum morphogenesis | 1.53e-04 | 28 | 77 | 3 | GO:0003148 | |
| GeneOntologyBiologicalProcess | heart looping | 1.61e-04 | 73 | 77 | 4 | GO:0001947 | |
| GeneOntologyBiologicalProcess | monoterpenoid metabolic process | 2.04e-04 | 6 | 77 | 2 | GO:0016098 | |
| GeneOntologyBiologicalProcess | determination of heart left/right asymmetry | 2.18e-04 | 79 | 77 | 4 | GO:0061371 | |
| GeneOntologyBiologicalProcess | embryonic heart tube morphogenesis | 2.29e-04 | 80 | 77 | 4 | GO:0003143 | |
| GeneOntologyBiologicalProcess | metal ion transport | CACNA2D4 MAGED2 KCNQ4 KCNJ3 UMOD UBR3 CACNA1I SLC5A8 SLC25A25 ATP2B3 OPA1 PLCE1 | 3.15e-04 | 1000 | 77 | 12 | GO:0030001 |
| GeneOntologyBiologicalProcess | xenobiotic catabolic process | 3.55e-04 | 37 | 77 | 3 | GO:0042178 | |
| GeneOntologyBiologicalProcess | positive regulation of cardiac muscle cell proliferation | 3.84e-04 | 38 | 77 | 3 | GO:0060045 | |
| GeneOntologyCellularComponent | intercellular bridge | 1.39e-06 | 94 | 78 | 6 | GO:0045171 | |
| GeneOntologyCellularComponent | tubulin complex | 4.11e-05 | 3 | 78 | 2 | GO:0045298 | |
| GeneOntologyCellularComponent | mitotic spindle | 1.06e-04 | 201 | 78 | 6 | GO:0072686 | |
| HumanPheno | Dysgenesis of the basal ganglia | 3.79e-06 | 5 | 38 | 3 | HP:0025102 | |
| Domain | Beta-tubulin_BS | 7.69e-13 | 10 | 76 | 6 | IPR013838 | |
| Domain | Beta_tubulin | 7.69e-13 | 10 | 76 | 6 | IPR002453 | |
| Domain | TUBULIN_B_AUTOREG | 1.69e-12 | 11 | 76 | 6 | PS00228 | |
| Domain | TF_T-box | 4.43e-11 | 17 | 76 | 6 | IPR001699 | |
| Domain | TBOX | 4.43e-11 | 17 | 76 | 6 | SM00425 | |
| Domain | TF_T-box_CS | 4.43e-11 | 17 | 76 | 6 | IPR018186 | |
| Domain | - | 4.43e-11 | 17 | 76 | 6 | 2.60.40.820 | |
| Domain | TBOX_3 | 4.43e-11 | 17 | 76 | 6 | PS50252 | |
| Domain | T-box | 4.43e-11 | 17 | 76 | 6 | PF00907 | |
| Domain | TBOX_1 | 4.43e-11 | 17 | 76 | 6 | PS01283 | |
| Domain | TBOX_2 | 4.43e-11 | 17 | 76 | 6 | PS01264 | |
| Domain | - | 1.38e-10 | 20 | 76 | 6 | 3.30.1330.20 | |
| Domain | - | 1.92e-10 | 21 | 76 | 6 | 1.10.287.600 | |
| Domain | Tubulin_C | 2.63e-10 | 22 | 76 | 6 | SM00865 | |
| Domain | Tubulin_C | 2.63e-10 | 22 | 76 | 6 | PF03953 | |
| Domain | Tubulin/FtsZ_2-layer-sand-dom | 2.63e-10 | 22 | 76 | 6 | IPR018316 | |
| Domain | - | 2.63e-10 | 22 | 76 | 6 | 3.40.50.1440 | |
| Domain | Tubulin_C | 3.55e-10 | 23 | 76 | 6 | IPR023123 | |
| Domain | TUBULIN | 3.55e-10 | 23 | 76 | 6 | PS00227 | |
| Domain | Tubulin | 3.55e-10 | 23 | 76 | 6 | IPR000217 | |
| Domain | Tub_FtsZ_C | 3.55e-10 | 23 | 76 | 6 | IPR008280 | |
| Domain | Tubulin | 3.55e-10 | 23 | 76 | 6 | SM00864 | |
| Domain | Tubulin_CS | 3.55e-10 | 23 | 76 | 6 | IPR017975 | |
| Domain | Tubulin_FtsZ_GTPase | 4.71e-10 | 24 | 76 | 6 | IPR003008 | |
| Domain | Tubulin | 4.71e-10 | 24 | 76 | 6 | PF00091 | |
| Domain | p53-like_TF_DNA-bd | 7.32e-08 | 53 | 76 | 6 | IPR008967 | |
| Domain | DUF1981 | 2.58e-07 | 4 | 76 | 3 | PF09324 | |
| Domain | Sec7_N | 2.58e-07 | 4 | 76 | 3 | IPR032691 | |
| Domain | Sec7_N | 2.58e-07 | 4 | 76 | 3 | PF12783 | |
| Domain | DCB_dom | 2.58e-07 | 4 | 76 | 3 | IPR032629 | |
| Domain | DCB | 2.58e-07 | 4 | 76 | 3 | PF16213 | |
| Domain | Sec7_C | 2.58e-07 | 4 | 76 | 3 | IPR015403 | |
| Domain | TF_Brachyury | 1.28e-06 | 6 | 76 | 3 | IPR002070 | |
| Domain | Cyt_P450_E_grp-I_CYP2B-like | 4.89e-05 | 3 | 76 | 2 | IPR008068 | |
| Domain | RecF/RecN/SMC_N | 4.50e-04 | 8 | 76 | 2 | IPR003395 | |
| Domain | SMC_N | 4.50e-04 | 8 | 76 | 2 | PF02463 | |
| Domain | Cyt_P450_E_grp-I | 8.13e-04 | 45 | 76 | 3 | IPR002401 | |
| Domain | Cyt_P450_CS | 1.31e-03 | 53 | 76 | 3 | IPR017972 | |
| Domain | CYTOCHROME_P450 | 1.62e-03 | 57 | 76 | 3 | PS00086 | |
| Domain | - | 1.66e-03 | 15 | 76 | 2 | 1.10.1000.11 | |
| Domain | Sec7 | 1.66e-03 | 15 | 76 | 2 | PF01369 | |
| Domain | Sec7_alpha_orthog | 1.66e-03 | 15 | 76 | 2 | IPR023394 | |
| Domain | - | 1.70e-03 | 58 | 76 | 3 | 1.10.630.10 | |
| Domain | p450 | 1.70e-03 | 58 | 76 | 3 | PF00067 | |
| Domain | Cyt_P450 | 1.88e-03 | 60 | 76 | 3 | IPR001128 | |
| Domain | Sec7 | 1.89e-03 | 16 | 76 | 2 | SM00222 | |
| Domain | SEC7 | 1.89e-03 | 16 | 76 | 2 | PS50190 | |
| Domain | Sec7_dom | 1.89e-03 | 16 | 76 | 2 | IPR000904 | |
| Domain | P-loop_NTPase | 2.23e-03 | 848 | 76 | 10 | IPR027417 | |
| Domain | ARM-type_fold | 2.57e-03 | 339 | 76 | 6 | IPR016024 | |
| Domain | - | 3.21e-03 | 746 | 76 | 9 | 3.40.50.300 | |
| Domain | UDPGT | 3.26e-03 | 21 | 76 | 2 | PF00201 | |
| Domain | UDPGT | 3.26e-03 | 21 | 76 | 2 | PS00375 | |
| Domain | UDP_glucos_trans | 3.26e-03 | 21 | 76 | 2 | IPR002213 | |
| Domain | Sugar_transporter_CS | 7.49e-03 | 32 | 76 | 2 | IPR005829 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_ESPG_TO_MICROTUBULE_RHOA_SIGNALING_PATHWAY | 1.31e-10 | 17 | 69 | 6 | M47768 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_DCTN1_TO_RETROGRADE_AXONAL_TRANSPORT | 1.95e-10 | 18 | 69 | 6 | M47753 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_IRON_TO_ANTEROGRADE_AXONAL_TRANSPORT | 2.84e-10 | 19 | 69 | 6 | M47818 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_ZN_TO_ANTEROGRADE_AXONAL_TRANSPORT | 2.84e-10 | 19 | 69 | 6 | M47813 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KINETOCHORE_MICROTUBULE_ATTACHMENT | 4.04e-10 | 20 | 69 | 6 | M47890 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_DEPOLYMERIZATION_AT_THE_MINUS_ENDS | 4.04e-10 | 20 | 69 | 6 | M47911 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_RHOA_SIGNALING_PATHWAY | 5.64e-10 | 21 | 69 | 6 | M47767 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PROMOTION_OF_MICROTUBULE_GROWTH | 7.73e-10 | 22 | 69 | 6 | M47903 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_DEPOLYMERIZATION | 1.04e-09 | 23 | 69 | 6 | M47910 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KINETOCHORE_FIBER_ORGANIZATION | 1.04e-09 | 23 | 69 | 6 | M47900 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANTEROGRADE_AXONAL_TRANSPORT | 1.38e-09 | 24 | 69 | 6 | M47671 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_ANTEROGRADE_AXONAL_TRANSPORT | 1.38e-09 | 24 | 69 | 6 | M47700 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SALMONELLA_SIFA_TO_MICROTUBULE_PLUS_END_DIRECTED_TRANSPORT | 1.81e-09 | 25 | 69 | 6 | M47775 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SNCA_TO_ANTEROGRADE_AXONAL_TRANSPORT | 1.81e-09 | 25 | 69 | 6 | M47710 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_ANTEROGRADE_AXONAL_TRANSPORT | 2.35e-09 | 26 | 69 | 6 | M47672 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_NUCLEATION | 3.81e-09 | 28 | 69 | 6 | M47898 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BRANCHING_MICROTUBULE_NUCLEATION | 1.10e-08 | 33 | 69 | 6 | M47901 | |
| Pathway | REACTOME_TRANSPORT_OF_CONNEXONS_TO_THE_PLASMA_MEMBRANE | 1.43e-08 | 17 | 69 | 5 | MM14731 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ARL8_REGULATED_MICROTUBULE_PLUS_END_DIRECTED_TRANSPORT | 1.60e-08 | 35 | 69 | 6 | M47774 | |
| Pathway | REACTOME_TRANSPORT_OF_CONNEXONS_TO_THE_PLASMA_MEMBRANE | 4.64e-08 | 21 | 69 | 5 | M27067 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RETROGRADE_AXONAL_TRANSPORT | 5.82e-08 | 43 | 69 | 6 | M47669 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RAB7_REGULATED_MICROTUBULE_MINUS_END_DIRECTED_TRANSPORT | 5.82e-08 | 43 | 69 | 6 | M47773 | |
| Pathway | REACTOME_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY | 7.62e-08 | 23 | 69 | 5 | M19135 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_RETROGRADE_AXONAL_TRANSPORT | 7.72e-08 | 45 | 69 | 6 | M47670 | |
| Pathway | REACTOME_CARBOXYTERMINAL_POST_TRANSLATIONAL_MODIFICATIONS_OF_TUBULIN | 8.84e-08 | 46 | 69 | 6 | M27828 | |
| Pathway | REACTOME_FORMATION_OF_TUBULIN_FOLDING_INTERMEDIATES_BY_CCT_TRIC | 1.47e-07 | 26 | 69 | 5 | M9648 | |
| Pathway | REACTOME_CARBOXYTERMINAL_POST_TRANSLATIONAL_MODIFICATIONS_OF_TUBULIN | 1.80e-07 | 27 | 69 | 5 | MM15549 | |
| Pathway | REACTOME_SEALING_OF_THE_NUCLEAR_ENVELOPE_NE_BY_ESCRT_III | 1.80e-07 | 27 | 69 | 5 | MM15674 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_IQGAPS | 2.63e-07 | 29 | 69 | 5 | MM15219 | |
| Pathway | REACTOME_ACTIVATION_OF_AMPK_DOWNSTREAM_OF_NMDARS | 2.63e-07 | 29 | 69 | 5 | M27948 | |
| Pathway | WP_PATHOGENIC_ESCHERICHIA_COLI_INFECTION | 2.64e-07 | 55 | 69 | 6 | M39613 | |
| Pathway | KEGG_PATHOGENIC_ESCHERICHIA_COLI_INFECTION | 2.95e-07 | 56 | 69 | 6 | M2333 | |
| Pathway | REACTOME_SEALING_OF_THE_NUCLEAR_ENVELOPE_NE_BY_ESCRT_III | 4.41e-07 | 32 | 69 | 5 | M29848 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_IQGAPS | 4.41e-07 | 32 | 69 | 5 | M27491 | |
| Pathway | REACTOME_GAP_JUNCTION_ASSEMBLY | 4.41e-07 | 32 | 69 | 5 | MM14730 | |
| Pathway | REACTOME_COOPERATION_OF_PREFOLDIN_AND_TRIC_CCT_IN_ACTIN_AND_TUBULIN_FOLDING | 5.17e-07 | 33 | 69 | 5 | M27297 | |
| Pathway | REACTOME_AGGREPHAGY | 8.13e-07 | 36 | 69 | 5 | MM15669 | |
| Pathway | REACTOME_RECYCLING_PATHWAY_OF_L1 | 9.36e-07 | 37 | 69 | 5 | MM15102 | |
| Pathway | REACTOME_GAP_JUNCTION_ASSEMBLY | 1.07e-06 | 38 | 69 | 5 | M14981 | |
| Pathway | WP_PARKINUBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY | 1.23e-06 | 71 | 69 | 6 | M39690 | |
| Pathway | REACTOME_GAP_JUNCTION_TRAFFICKING_AND_REGULATION | 2.27e-06 | 44 | 69 | 5 | MM14606 | |
| Pathway | REACTOME_AGGREPHAGY | 2.27e-06 | 44 | 69 | 5 | M29830 | |
| Pathway | REACTOME_ASSEMBLY_AND_CELL_SURFACE_PRESENTATION_OF_NMDA_RECEPTORS | 2.27e-06 | 44 | 69 | 5 | M27934 | |
| Pathway | REACTOME_COPI_INDEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 3.53e-06 | 48 | 69 | 5 | MM15353 | |
| Pathway | REACTOME_RECYCLING_PATHWAY_OF_L1 | 3.91e-06 | 49 | 69 | 5 | M891 | |
| Pathway | REACTOME_GAP_JUNCTION_TRAFFICKING_AND_REGULATION | 4.78e-06 | 51 | 69 | 5 | M26972 | |
| Pathway | KEGG_GAP_JUNCTION | 4.97e-06 | 90 | 69 | 6 | M4013 | |
| Pathway | REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES | 4.97e-06 | 90 | 69 | 6 | MM14979 | |
| Pathway | REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND | 5.27e-06 | 52 | 69 | 5 | MM14949 | |
| Pathway | REACTOME_INTRAFLAGELLAR_TRANSPORT | 5.27e-06 | 52 | 69 | 5 | MM15211 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_FORMINS | 5.29e-06 | 140 | 69 | 7 | M27550 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_FORMINS | 5.55e-06 | 141 | 69 | 7 | MM15266 | |
| Pathway | REACTOME_COPI_INDEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 5.80e-06 | 53 | 69 | 5 | M27651 | |
| Pathway | REACTOME_INTRAFLAGELLAR_TRANSPORT | 6.37e-06 | 54 | 69 | 5 | M27482 | |
| Pathway | REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES | 6.80e-06 | 95 | 69 | 6 | M6729 | |
| Pathway | REACTOME_PROTEIN_FOLDING | 8.14e-06 | 98 | 69 | 6 | M776 | |
| Pathway | REACTOME_KINESINS | 8.34e-06 | 57 | 69 | 5 | MM15714 | |
| Pathway | REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND | 8.34e-06 | 57 | 69 | 5 | M27251 | |
| Pathway | REACTOME_KINESINS | 1.17e-05 | 61 | 69 | 5 | M977 | |
| Pathway | REACTOME_PKR_MEDIATED_SIGNALING | 1.72e-05 | 66 | 69 | 5 | MM17074 | |
| Pathway | REACTOME_CYP2E1_REACTIONS | 1.80e-05 | 11 | 69 | 3 | M27130 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_NE_REASSEMBLY | 1.99e-05 | 68 | 69 | 5 | MM14921 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 1.99e-05 | 68 | 69 | 5 | MM14968 | |
| Pathway | REACTOME_TRANSLOCATION_OF_SLC2A4_GLUT4_TO_THE_PLASMA_MEMBRANE | 2.63e-05 | 72 | 69 | 5 | M26954 | |
| Pathway | REACTOME_THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT | 2.81e-05 | 73 | 69 | 5 | MM15491 | |
| Pathway | REACTOME_SELECTIVE_AUTOPHAGY | 2.81e-05 | 73 | 69 | 5 | MM15672 | |
| Pathway | REACTOME_PKR_MEDIATED_SIGNALING | 3.42e-05 | 76 | 69 | 5 | M48037 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_NE_REASSEMBLY | 3.42e-05 | 76 | 69 | 5 | M27215 | |
| Pathway | REACTOME_THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT | 4.13e-05 | 79 | 69 | 5 | M27743 | |
| Pathway | REACTOME_CILIUM_ASSEMBLY | 5.51e-05 | 201 | 69 | 7 | M27472 | |
| Pathway | REACTOME_MITOTIC_PROMETAPHASE | 5.69e-05 | 202 | 69 | 7 | MM15362 | |
| Pathway | REACTOME_MITOTIC_PROMETAPHASE | 6.05e-05 | 204 | 69 | 7 | M4217 | |
| Pathway | WP_HEART_DEVELOPMENT | 7.35e-05 | 46 | 69 | 4 | MM15884 | |
| Pathway | REACTOME_SELECTIVE_AUTOPHAGY | 7.72e-05 | 90 | 69 | 5 | M29841 | |
| Pathway | WP_HEART_DEVELOPMENT | 8.00e-05 | 47 | 69 | 4 | M39610 | |
| Pathway | REACTOME_ORGANELLE_BIOGENESIS_AND_MAINTENANCE | 8.93e-05 | 217 | 69 | 7 | MM14708 | |
| Pathway | REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS | 9.50e-05 | 94 | 69 | 5 | M2843 | |
| Pathway | REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES | 9.50e-05 | 94 | 69 | 5 | MM14515 | |
| Pathway | REACTOME_COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 1.16e-04 | 98 | 69 | 5 | MM15352 | |
| Pathway | REACTOME_COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 1.27e-04 | 100 | 69 | 5 | M27650 | |
| Pathway | REACTOME_COPI_MEDIATED_ANTEROGRADE_TRANSPORT | 1.40e-04 | 102 | 69 | 5 | M27648 | |
| Pathway | REACTOME_HEDGEHOG_OFF_STATE | 1.60e-04 | 105 | 69 | 5 | MM15206 | |
| Pathway | REACTOME_XENOBIOTICS | 1.85e-04 | 23 | 69 | 3 | M5372 | |
| Pathway | REACTOME_COPI_MEDIATED_ANTEROGRADE_TRANSPORT | 1.99e-04 | 110 | 69 | 5 | MM15350 | |
| Pathway | REACTOME_HEDGEHOG_OFF_STATE | 2.26e-04 | 113 | 69 | 5 | M27471 | |
| Pathway | REACTOME_XENOBIOTICS | 2.39e-04 | 25 | 69 | 3 | MM14846 | |
| Pathway | REACTOME_RHO_GTPASE_EFFECTORS | 2.54e-04 | 257 | 69 | 7 | MM14755 | |
| Pathway | REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION | 2.56e-04 | 116 | 69 | 5 | MM14855 | |
| Pathway | REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION | 2.56e-04 | 116 | 69 | 5 | MM15715 | |
| Pathway | KEGG_RETINOL_METABOLISM | 2.68e-04 | 64 | 69 | 4 | M9488 | |
| Pathway | REACTOME_MITOTIC_G2_G2_M_PHASES | 2.76e-04 | 184 | 69 | 6 | MM15145 | |
| Pathway | REACTOME_CARDIOGENESIS | 3.02e-04 | 27 | 69 | 3 | M48011 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 3.11e-04 | 121 | 69 | 5 | M872 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | 3.43e-04 | 270 | 69 | 7 | M15514 | |
| Pathway | REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION | 3.75e-04 | 126 | 69 | 5 | M705 | |
| Pathway | KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450 | 3.78e-04 | 70 | 69 | 4 | M16794 | |
| Pathway | REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION | 3.89e-04 | 127 | 69 | 5 | M27181 | |
| Pathway | REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION | 4.18e-04 | 129 | 69 | 5 | MM14894 | |
| Pathway | KEGG_DRUG_METABOLISM_CYTOCHROME_P450 | 4.21e-04 | 72 | 69 | 4 | M9257 | |
| Pathway | REACTOME_MITOTIC_G2_G2_M_PHASES | 4.31e-04 | 200 | 69 | 6 | M864 | |
| Pubmed | Mutations in the β-tubulin gene TUBB5 cause microcephaly with structural brain abnormalities. | 2.92e-15 | 8 | 78 | 6 | 23246003 | |
| Pubmed | Mitochondria-cytoskeleton interaction: distribution of β-tubulins in cardiomyocytes and HL-1 cells. | 4.98e-14 | 5 | 78 | 5 | 21296049 | |
| Pubmed | 2.98e-13 | 6 | 78 | 5 | 3782288 | ||
| Pubmed | 5.52e-12 | 21 | 78 | 6 | 30110642 | ||
| Pubmed | Systematic Analysis of the Functions of Lysine Acetylation in the Regulation of Tat Activity. | 7.58e-12 | 22 | 78 | 6 | 23826228 | |
| Pubmed | Modifications in the human T cell proteome induced by intracellular HIV-1 Tat protein expression. | 7.58e-12 | 22 | 78 | 6 | 16526095 | |
| Pubmed | TUBB1 mutations cause thyroid dysgenesis associated with abnormal platelet physiology. | 7.58e-12 | 22 | 78 | 6 | 30446499 | |
| Pubmed | 2.34e-11 | 4 | 78 | 4 | 11120798 | ||
| Pubmed | 3.02e-10 | 17 | 78 | 5 | 17360745 | ||
| Pubmed | 3.50e-10 | 6 | 78 | 4 | 24275654 | ||
| Pubmed | 3.78e-10 | 40 | 78 | 6 | 30865227 | ||
| Pubmed | 5.65e-10 | 19 | 78 | 5 | 15691386 | ||
| Pubmed | 5.65e-10 | 19 | 78 | 5 | 15698476 | ||
| Pubmed | 8.15e-10 | 7 | 78 | 4 | 27010057 | ||
| Pubmed | PEX14 is required for microtubule-based peroxisome motility in human cells. | 2.48e-09 | 54 | 78 | 6 | 21525035 | |
| Pubmed | 2.73e-09 | 99 | 78 | 7 | 29676259 | ||
| Pubmed | USP11 mediates repair of DNA-protein cross-links by deubiquitinating SPRTN metalloprotease. | TUBB3 TUBB4A TUBB4B MAGED2 CHST4 TUBB TUBB2B CPS1 RFC5 TUBB2A PHGDH HNRNPH2 | 4.93e-09 | 565 | 78 | 12 | 33567341 |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | TUBB3 TUBB4A TUBB4B TK1 NOL6 TUBB SMC4 TUBB2B CPS1 RFC5 VIRMA HNRNPH2 RAD50 | 5.66e-09 | 704 | 78 | 13 | 29955894 |
| Pubmed | 6.79e-09 | 30 | 78 | 5 | 25864199 | ||
| Pubmed | 8.63e-09 | 183 | 78 | 8 | 23956138 | ||
| Pubmed | 1.09e-08 | 3 | 78 | 3 | 23834474 | ||
| Pubmed | β-Tubulin mutations that cause severe neuropathies disrupt axonal transport. | 1.09e-08 | 3 | 78 | 3 | 23503589 | |
| Pubmed | Tubulin beta 3 and 4 are involved in the generation of early fibrotic stages. | 1.09e-08 | 3 | 78 | 3 | 28648944 | |
| Pubmed | 1.09e-08 | 3 | 78 | 3 | 6688039 | ||
| Pubmed | Pharmacogenetics of cyclophosphamide in patients with hematological malignancies. | 1.09e-08 | 3 | 78 | 3 | 16183265 | |
| Pubmed | 1.09e-08 | 3 | 78 | 3 | 16338275 | ||
| Pubmed | 1.13e-08 | 33 | 78 | 5 | 18356246 | ||
| Pubmed | The glutamine-rich region of the HIV-1 Tat protein is involved in T-cell apoptosis. | 1.14e-08 | 12 | 78 | 4 | 15331610 | |
| Pubmed | Quantitative interactome proteomics identifies a proteostasis network for GABAA receptors. | 1.40e-08 | 125 | 78 | 7 | 36030824 | |
| Pubmed | HIV-1 rev depolymerizes microtubules to form stable bilayered rings. | 1.65e-08 | 13 | 78 | 4 | 10908577 | |
| Pubmed | 2.30e-08 | 14 | 78 | 4 | 12486001 | ||
| Pubmed | Noncanonical regulation of alkylation damage resistance by the OTUD4 deubiquitinase. | 2.70e-08 | 39 | 78 | 5 | 25944111 | |
| Pubmed | 4.17e-08 | 16 | 78 | 4 | 14594945 | ||
| Pubmed | 4.33e-08 | 4 | 78 | 3 | 15248218 | ||
| Pubmed | 4.33e-08 | 4 | 78 | 3 | 19545277 | ||
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 6.04e-08 | 332 | 78 | 9 | 32786267 | |
| Pubmed | 8.83e-08 | 247 | 78 | 8 | 30713523 | ||
| Pubmed | 1.08e-07 | 51 | 78 | 5 | 36896912 | ||
| Pubmed | Pharmacogenetic testing for clopidogrel using the rapid INFINITI analyzer: a dose-escalation study. | 1.08e-07 | 5 | 78 | 3 | 19926050 | |
| Pubmed | 1.08e-07 | 5 | 78 | 3 | 19414633 | ||
| Pubmed | 1.08e-07 | 5 | 78 | 3 | 18024866 | ||
| Pubmed | Five mouse tubulin isotypes and their regulated expression during development. | 1.08e-07 | 5 | 78 | 3 | 3839797 | |
| Pubmed | Association of cyclophosphamide pharmacokinetics to polymorphic cytochrome P450 2C19. | 1.08e-07 | 5 | 78 | 3 | 16116487 | |
| Pubmed | 1.08e-07 | 5 | 78 | 3 | 19029318 | ||
| Pubmed | 1.08e-07 | 5 | 78 | 3 | 19106084 | ||
| Pubmed | TUBB3 TUBB4A TUBB SMC4 UGT8 TUBB2B CPS1 RFC5 PHGDH HNRNPH2 RAD50 | 1.25e-07 | 613 | 78 | 11 | 22268729 | |
| Pubmed | 2.16e-07 | 6 | 78 | 3 | 17900275 | ||
| Pubmed | 2.16e-07 | 6 | 78 | 3 | 20179710 | ||
| Pubmed | Induction and genetic regulation of mouse hepatic cytochrome P450 by cannabidiol. | 2.16e-07 | 6 | 78 | 3 | 8043019 | |
| Pubmed | 2.16e-07 | 6 | 78 | 3 | 18613978 | ||
| Pubmed | Evolution of mouse T-box genes by tandem duplication and cluster dispersion. | 2.16e-07 | 6 | 78 | 3 | 8878690 | |
| Pubmed | TUBB3 TUBB4A TUBB4B ABCA13 UGT2A3 TUBB UGT8 TUBB2B TUBB2A AGTPBP1 | 2.29e-07 | 513 | 78 | 10 | 25798074 | |
| Pubmed | 2.56e-07 | 284 | 78 | 8 | 29459677 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | TUBB3 TUBB4B MAGED2 TK1 NOL6 TUBB SMC4 TUBB2B SRCAP RFC5 MGA PHGDH HNRNPH2 RBM34 RAD50 | 2.86e-07 | 1353 | 78 | 15 | 29467282 |
| Pubmed | 3.10e-07 | 403 | 78 | 9 | 30562941 | ||
| Pubmed | 3.27e-07 | 198 | 78 | 7 | 24337577 | ||
| Pubmed | 3.37e-07 | 407 | 78 | 9 | 12693553 | ||
| Pubmed | Association of polo-like kinase with alpha-, beta- and gamma-tubulins in a stable complex. | 3.77e-07 | 7 | 78 | 3 | 10191277 | |
| Pubmed | 4.27e-07 | 206 | 78 | 7 | 22174317 | ||
| Pubmed | 4.47e-07 | 421 | 78 | 9 | 34650049 | ||
| Pubmed | Identification of Zika Virus and Dengue Virus Dependency Factors using Functional Genomics. | 4.56e-07 | 422 | 78 | 9 | 27342126 | |
| Pubmed | Identification and characterization of human FNBP3 gene in silico. | 6.03e-07 | 8 | 78 | 3 | 12964049 | |
| Pubmed | ABCB1 and cytochrome P450 polymorphisms: clinical pharmacogenetics of clozapine. | 6.03e-07 | 8 | 78 | 3 | 19593168 | |
| Pubmed | 6.03e-07 | 8 | 78 | 3 | 18356043 | ||
| Pubmed | 6.03e-07 | 8 | 78 | 3 | 22164283 | ||
| Pubmed | 6.03e-07 | 8 | 78 | 3 | 18854779 | ||
| Pubmed | TUBB3 TUBB4A TUBB4B TUBB CPS1 RFC5 TUBB2A OPA1 PHGDH HNRNPH2 RBM34 | 6.56e-07 | 725 | 78 | 11 | 27025967 | |
| Pubmed | 8.40e-07 | 142 | 78 | 6 | 30809309 | ||
| Pubmed | 9.03e-07 | 9 | 78 | 3 | 18496131 | ||
| Pubmed | 9.03e-07 | 9 | 78 | 3 | 17178267 | ||
| Pubmed | Proteomic analysis reveals novel binding partners of MIP-T3 in human cells. | 1.03e-06 | 34 | 78 | 4 | 20391533 | |
| Pubmed | Expanding the Interactome of TES by Exploiting TES Modules with Different Subcellular Localizations. | 1.03e-06 | 235 | 78 | 7 | 28378594 | |
| Pubmed | USP45 and Spindly are part of the same complex implicated in cell migration. | 1.03e-06 | 235 | 78 | 7 | 30258100 | |
| Pubmed | 1.07e-06 | 148 | 78 | 6 | 35676246 | ||
| Pubmed | 1.29e-06 | 10 | 78 | 3 | 19651758 | ||
| Pubmed | Postnatal refinement of auditory hair cell planar polarity deficits occurs in the absence of Vangl2. | 1.29e-06 | 10 | 78 | 3 | 23986237 | |
| Pubmed | TUBB3 TUBB4A TUBB4B MAGED2 TUBB MPDZ DHX32 RFC5 TUBB2A OPA1 PHGDH HNRNPH2 RBM34 RAD50 | 1.45e-06 | 1335 | 78 | 14 | 29229926 | |
| Pubmed | 1.77e-06 | 11 | 78 | 3 | 15039299 | ||
| Pubmed | Genetic variation in eleven phase I drug metabolism genes in an ethnically diverse population. | 1.77e-06 | 11 | 78 | 3 | 15469410 | |
| Pubmed | Differential requirements of tubulin genes in mammalian forebrain development. | 1.77e-06 | 11 | 78 | 3 | 31386652 | |
| Pubmed | 2.09e-06 | 655 | 78 | 10 | 35819319 | ||
| Pubmed | 2.09e-06 | 166 | 78 | 6 | 34687317 | ||
| Pubmed | HEY1 functions are regulated by its phosphorylation at Ser-68. | 2.47e-06 | 95 | 78 | 5 | 27129302 | |
| Pubmed | TUBB3 TUBB4A TUBB4B MAGED2 TUBB DHX32 TUBB2B TUBB2A OPA1 PHGDH HNRNPH2 | 2.85e-06 | 844 | 78 | 11 | 25963833 | |
| Pubmed | 3.05e-06 | 13 | 78 | 3 | 19696793 | ||
| Pubmed | TUBB3 TUBB4A TUBB4B SV2A TUBB ARFGEF2 TUBB2B RIMS1 VIRMA ATP2B3 TUBB2A OPA1 PHGDH AGTPBP1 | 3.25e-06 | 1431 | 78 | 14 | 37142655 | |
| Pubmed | 3.63e-06 | 405 | 78 | 8 | 38187761 | ||
| Pubmed | 3.85e-06 | 104 | 78 | 5 | 36055981 | ||
| Pubmed | CTDP1 regulates breast cancer survival and DNA repair through BRCT-specific interactions with FANCI. | 3.85e-06 | 104 | 78 | 5 | 31240132 | |
| Pubmed | Novel DNA sequence variations of cytochrome P450 genes in the Han Chinese population. | 3.88e-06 | 14 | 78 | 3 | 19290787 | |
| Pubmed | 3.88e-06 | 14 | 78 | 3 | 20970553 | ||
| Pubmed | 4.05e-06 | 411 | 78 | 8 | 36652389 | ||
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | MON2 TUBB3 TUBB4A TUBB4B MAGED2 TUBB SMC4 TUBB2B RFC5 TUBB2A OPA1 PHGDH HNRNPH2 | 4.20e-06 | 1257 | 78 | 13 | 37317656 |
| Pubmed | SPATA2 Links CYLD to LUBAC, Activates CYLD, and Controls LUBAC Signaling. | 4.51e-06 | 558 | 78 | 9 | 27591049 | |
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 16198656 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 30621030 | ||
| Pubmed | [Association between genetic polymorphisms of CYP2C19 and CYP2C9 and phenytoin serum concentration]. | 4.97e-06 | 2 | 78 | 2 | 15569425 | |
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 17627938 | ||
| Pubmed | Effect of CYP2B6*6 and CYP2C19*2 genotype on chlorpyrifos metabolism. | 4.97e-06 | 2 | 78 | 2 | 22281205 | |
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 17407229 | ||
| Interaction | ZC2HC1B interactions | 1.10e-11 | 28 | 78 | 7 | int:ZC2HC1B | |
| Interaction | TPSB2 interactions | 4.94e-11 | 18 | 78 | 6 | int:TPSB2 | |
| Interaction | CAPS interactions | 4.62e-10 | 25 | 78 | 6 | int:CAPS | |
| Interaction | TCP11L1 interactions | 4.77e-10 | 75 | 78 | 8 | int:TCP11L1 | |
| Interaction | MGARP interactions | MON2 ESRP2 TUBB3 TUBB4A TUBB4B MAGED2 TUBB ARFGEF2 ARFGEF1 SLC25A25 BDH1 | 9.21e-10 | 222 | 78 | 11 | int:MGARP |
| Interaction | TMPRSS5 interactions | 2.98e-08 | 48 | 78 | 6 | int:TMPRSS5 | |
| Interaction | LRP1 interactions | 6.62e-08 | 196 | 78 | 9 | int:LRP1 | |
| Interaction | EML1 interactions | 1.66e-07 | 33 | 78 | 5 | int:EML1 | |
| Interaction | EML2 interactions | 3.46e-07 | 38 | 78 | 5 | int:EML2 | |
| Interaction | OSTM1 interactions | 6.62e-07 | 80 | 78 | 6 | int:OSTM1 | |
| Interaction | RSPH1 interactions | 7.51e-07 | 131 | 78 | 7 | int:RSPH1 | |
| Interaction | GLMP interactions | 8.84e-07 | 84 | 78 | 6 | int:GLMP | |
| Interaction | EML4 interactions | 1.02e-06 | 137 | 78 | 7 | int:EML4 | |
| Interaction | IL12RB1 interactions | 1.09e-06 | 87 | 78 | 6 | int:IL12RB1 | |
| Interaction | GABRA1 interactions | 2.04e-06 | 152 | 78 | 7 | int:GABRA1 | |
| Interaction | ASB17 interactions | 2.47e-06 | 25 | 78 | 4 | int:ASB17 | |
| Interaction | METTL22 interactions | 2.91e-06 | 26 | 78 | 4 | int:METTL22 | |
| Interaction | SPRTN interactions | TUBB3 TUBB4A TUBB4B MAGED2 CHST4 TUBB TUBB2B CPS1 RFC5 TUBB2A PHGDH HNRNPH2 | 2.93e-06 | 596 | 78 | 12 | int:SPRTN |
| Interaction | FBXL4 interactions | 3.47e-06 | 106 | 78 | 6 | int:FBXL4 | |
| Interaction | ALKBH3 interactions | 3.83e-06 | 61 | 78 | 5 | int:ALKBH3 | |
| Interaction | KLK5 interactions | 4.08e-06 | 109 | 78 | 6 | int:KLK5 | |
| Interaction | MCM5 interactions | TUBB3 TUBB4A TUBB4B MAGED2 TUBB TUBB2B VIRMA TUBB2A PHGDH RAD50 | 4.94e-06 | 420 | 78 | 10 | int:MCM5 |
| Interaction | TTC5 interactions | 5.25e-06 | 65 | 78 | 5 | int:TTC5 | |
| Interaction | METTL23 interactions | 5.27e-06 | 30 | 78 | 4 | int:METTL23 | |
| Interaction | CDK20 interactions | 5.29e-06 | 114 | 78 | 6 | int:CDK20 | |
| Interaction | BAGE2 interactions | 7.58e-06 | 70 | 78 | 5 | int:BAGE2 | |
| Interaction | ELK1 interactions | 9.00e-06 | 125 | 78 | 6 | int:ELK1 | |
| Interaction | TUBB8B interactions | 9.00e-06 | 11 | 78 | 3 | int:TUBB8B | |
| Interaction | GZMH interactions | 9.97e-06 | 74 | 78 | 5 | int:GZMH | |
| Interaction | EML6 interactions | 1.20e-05 | 12 | 78 | 3 | int:EML6 | |
| Interaction | CCT7 interactions | TUBB3 TUBB4A TUBB4B VPS13A TUBB TUBB2B VIRMA TUBB2A DCAF5 WDR24 RAD50 | 1.28e-05 | 575 | 78 | 11 | int:CCT7 |
| Interaction | NEK4 interactions | TUBB3 TUBB4A TUBB4B ABCA13 UGT2A3 TUBB UGT8 TUBB2B VIRMA TUBB2A AGTPBP1 | 1.43e-05 | 582 | 78 | 11 | int:NEK4 |
| Interaction | LINC01554 interactions | 1.86e-05 | 142 | 78 | 6 | int:LINC01554 | |
| Interaction | CAPSL interactions | 2.45e-05 | 15 | 78 | 3 | int:CAPSL | |
| Interaction | FAM174A interactions | 2.58e-05 | 224 | 78 | 7 | int:FAM174A | |
| Interaction | AIFM1 interactions | TUBB3 TUBB4A TUBB4B TUBB ARFGEF1 TUBB2B SLC25A25 VIRMA BDH1 OPA1 PHGDH | 2.92e-05 | 629 | 78 | 11 | int:AIFM1 |
| Interaction | BSG interactions | MON2 TUBB3 TUBB4A TUBB4B TUBB ARFGEF2 ARFGEF1 SLC25A25 VIRMA ATP2B3 TUBB2A | 3.01e-05 | 631 | 78 | 11 | int:BSG |
| Interaction | FAM86B2 interactions | 3.01e-05 | 16 | 78 | 3 | int:FAM86B2 | |
| Interaction | TRAF3IP1 interactions | 3.54e-05 | 96 | 78 | 5 | int:TRAF3IP1 | |
| Interaction | KIF23 interactions | MAGED2 ABCA13 NOL6 SMC4 TNNC2 CPS1 RFC5 ECHS1 VIRMA ATP2B3 OPA1 PHGDH HNRNPH2 RBM34 | 3.68e-05 | 1031 | 78 | 14 | int:KIF23 |
| Interaction | COP1 interactions | 3.77e-05 | 326 | 78 | 8 | int:COP1 | |
| Interaction | FAF1 interactions | 4.48e-05 | 334 | 78 | 8 | int:FAF1 | |
| Interaction | PPEF1 interactions | 4.88e-05 | 52 | 78 | 4 | int:PPEF1 | |
| Interaction | NFXL1 interactions | 4.97e-05 | 103 | 78 | 5 | int:NFXL1 | |
| Interaction | RIPK4 interactions | 5.55e-05 | 446 | 78 | 9 | int:RIPK4 | |
| Interaction | ZUP1 interactions | 5.83e-05 | 174 | 78 | 6 | int:ZUP1 | |
| Interaction | EFNA3 interactions | 6.23e-05 | 108 | 78 | 5 | int:EFNA3 | |
| Interaction | TRIM31 interactions | 6.36e-05 | 454 | 78 | 9 | int:TRIM31 | |
| Interaction | RPGR interactions | 7.02e-05 | 57 | 78 | 4 | int:RPGR | |
| Interaction | DDRGK1 interactions | MON2 TUBB4A TUBB4B CYP2C9 GSPT2 MAGED2 TUBB SMC4 RFC5 NME4 VIRMA TUBB2A PHGDH HNRNPH2 RBM34 | 7.63e-05 | 1249 | 78 | 15 | int:DDRGK1 |
| Interaction | CDC42SE2 interactions | 8.15e-05 | 22 | 78 | 3 | int:CDC42SE2 | |
| Interaction | TUBA1C interactions | 9.42e-05 | 478 | 78 | 9 | int:TUBA1C | |
| Interaction | FBXO6 interactions | TUBB3 TUBB4A TUBB SMC4 UGT8 TUBB2B CPS1 RFC5 PHGDH HNRNPH2 RAD50 | 9.51e-05 | 717 | 78 | 11 | int:FBXO6 |
| Interaction | NPTN interactions | 1.01e-04 | 278 | 78 | 7 | int:NPTN | |
| Interaction | CSGALNACT1 interactions | 1.11e-04 | 64 | 78 | 4 | int:CSGALNACT1 | |
| Interaction | SLAMF1 interactions | 1.25e-04 | 125 | 78 | 5 | int:SLAMF1 | |
| Interaction | TUBA1B interactions | 1.28e-04 | 498 | 78 | 9 | int:TUBA1B | |
| Interaction | TSPYL6 interactions | 1.40e-04 | 68 | 78 | 4 | int:TSPYL6 | |
| Interaction | CYP2C19 interactions | 1.47e-04 | 5 | 78 | 2 | int:CYP2C19 | |
| Interaction | TEDC2 interactions | 1.48e-04 | 206 | 78 | 6 | int:TEDC2 | |
| Interaction | CTDP1 interactions | 1.52e-04 | 207 | 78 | 6 | int:CTDP1 | |
| Interaction | CYP2C18 interactions | 1.53e-04 | 27 | 78 | 3 | int:CYP2C18 | |
| Interaction | RICTOR interactions | TUBB3 TUBB4B TUBB SMC4 ARFGEF2 ARFGEF1 CPS1 MGA VIRMA PHGDH AGTPBP1 | 1.57e-04 | 759 | 78 | 11 | int:RICTOR |
| Interaction | TUBA4A interactions | 1.58e-04 | 512 | 78 | 9 | int:TUBA4A | |
| Interaction | ARL2 interactions | 1.61e-04 | 132 | 78 | 5 | int:ARL2 | |
| Interaction | GPR45 interactions | 1.62e-04 | 300 | 78 | 7 | int:GPR45 | |
| Interaction | OBSL1 interactions | TUBB4B NOL6 TUBB2B SRCAP RFC5 MGA TUBB2A PHGDH HNRNPH2 RBM34 AGTPBP1 RAD50 | 1.71e-04 | 902 | 78 | 12 | int:OBSL1 |
| Interaction | TUBB1 interactions | 1.91e-04 | 137 | 78 | 5 | int:TUBB1 | |
| Interaction | DYNC1I1 interactions | 2.05e-04 | 139 | 78 | 5 | int:DYNC1I1 | |
| Interaction | TRMT2A interactions | 2.05e-04 | 139 | 78 | 5 | int:TRMT2A | |
| Interaction | HEY1 interactions | 2.12e-04 | 140 | 78 | 5 | int:HEY1 | |
| Interaction | AAR2 interactions | 2.16e-04 | 657 | 78 | 10 | int:AAR2 | |
| Interaction | SPDL1 interactions | 2.18e-04 | 315 | 78 | 7 | int:SPDL1 | |
| Interaction | TBCD interactions | 2.19e-04 | 141 | 78 | 5 | int:TBCD | |
| Interaction | TUBB2A interactions | 2.22e-04 | 316 | 78 | 7 | int:TUBB2A | |
| Interaction | HDAC6 interactions | TUBB3 TUBB4A TUBB4B GSPT2 TUBB TUBB2B CPS1 VIRMA BDH1 TUBB2A PHGDH RAD50 | 2.25e-04 | 929 | 78 | 12 | int:HDAC6 |
| Interaction | UPK2 interactions | 2.26e-04 | 142 | 78 | 5 | int:UPK2 | |
| Interaction | USP11 interactions | 2.32e-04 | 539 | 78 | 9 | int:USP11 | |
| Interaction | MFSD4A interactions | 2.38e-04 | 225 | 78 | 6 | int:MFSD4A | |
| Interaction | B3GNT2 interactions | 2.42e-04 | 542 | 78 | 9 | int:B3GNT2 | |
| Interaction | MCM2 interactions | TUBB3 TUBB4A TUBB4B MAGED2 TUBB SMC4 DHX32 TUBB2B VIRMA TUBB2A OPA1 PHGDH HNRNPH2 | 2.42e-04 | 1081 | 78 | 13 | int:MCM2 |
| Interaction | ZBTB38 interactions | 2.49e-04 | 145 | 78 | 5 | int:ZBTB38 | |
| Interaction | NKX2-5 interactions | 2.89e-04 | 82 | 78 | 4 | int:NKX2-5 | |
| Interaction | TES interactions | 3.00e-04 | 332 | 78 | 7 | int:TES | |
| Interaction | ASB4 interactions | 3.06e-04 | 34 | 78 | 3 | int:ASB4 | |
| Interaction | ZSWIM5 interactions | 3.07e-04 | 7 | 78 | 2 | int:ZSWIM5 | |
| Interaction | PEX14 interactions | 3.15e-04 | 237 | 78 | 6 | int:PEX14 | |
| Interaction | AGO3 interactions | 3.19e-04 | 153 | 78 | 5 | int:AGO3 | |
| Interaction | CDK13 interactions | 3.19e-04 | 153 | 78 | 5 | int:CDK13 | |
| Interaction | RNF113A interactions | 3.27e-04 | 692 | 78 | 10 | int:RNF113A | |
| Interaction | AQP3 interactions | 3.29e-04 | 239 | 78 | 6 | int:AQP3 | |
| Interaction | PHB1 interactions | TUBB3 TUBB4A TUBB4B TUBB CPS1 RFC5 VIRMA TUBB2A OPA1 PHGDH HNRNPH2 YIPF3 RBM34 | 3.50e-04 | 1123 | 78 | 13 | int:PHB1 |
| Interaction | SLX4 interactions | 3.59e-04 | 572 | 78 | 9 | int:SLX4 | |
| Interaction | TUBB3 interactions | 3.63e-04 | 453 | 78 | 8 | int:TUBB3 | |
| Interaction | RUVBL1 interactions | 3.73e-04 | 575 | 78 | 9 | int:RUVBL1 | |
| Interaction | CYP2B6 interactions | 4.08e-04 | 8 | 78 | 2 | int:CYP2B6 | |
| Interaction | PIPSL interactions | 4.36e-04 | 252 | 78 | 6 | int:PIPSL | |
| Interaction | GAN interactions | 4.45e-04 | 253 | 78 | 6 | int:GAN | |
| Interaction | GFER interactions | 4.48e-04 | 92 | 78 | 4 | int:GFER | |
| Interaction | MEPCE interactions | TUBB3 TUBB4A TUBB4B MAGED2 TUBB SMC4 TUBB2B RFC5 TUBB2A PHGDH HNRNPH2 | 4.53e-04 | 859 | 78 | 11 | int:MEPCE |
| Cytoband | 6p25 | 3.37e-04 | 16 | 78 | 2 | 6p25 | |
| Cytoband | 10q24 | 1.64e-03 | 35 | 78 | 2 | 10q24 | |
| GeneFamily | T-boxes | 1.21e-11 | 18 | 56 | 6 | 766 | |
| GeneFamily | Tubulins | 1.47e-10 | 26 | 56 | 6 | 778 | |
| GeneFamily | Cytochrome P450 family 2 | 1.72e-04 | 35 | 56 | 3 | 1001 | |
| GeneFamily | Calcium voltage-gated channel subunits | 2.92e-03 | 26 | 56 | 2 | 253 | |
| GeneFamily | UDP glucuronosyltransferases | 4.40e-03 | 32 | 56 | 2 | 363 | |
| Coexpression | HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP | 6.51e-06 | 153 | 78 | 6 | M5588 | |
| Coexpression | HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP | 7.02e-06 | 155 | 78 | 6 | MM1259 | |
| Coexpression | BLUM_RESPONSE_TO_SALIRASIB_DN | 8.03e-06 | 341 | 78 | 8 | M2879 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_EARLY_MESOTHELIAL_CELL | PDPN TUBB4A TK1 VPS13A MAMSTR TUBB2B RIMS1 DISP1 SLC2A11 PLCE1 | 9.02e-06 | 584 | 78 | 10 | M45668 |
| Coexpression | DESCARTES_FETAL_PANCREAS_ENS_NEURONS | 1.00e-05 | 165 | 78 | 6 | M40270 | |
| Coexpression | DAZARD_UV_RESPONSE_CLUSTER_G4 | 2.79e-05 | 20 | 78 | 3 | M10885 | |
| Coexpression | SAENZ_DETOX_PATHWAY_AND_CARCINOGENESIS_DN | 2.79e-05 | 20 | 78 | 3 | MM1104 | |
| Coexpression | RAO_BOUND_BY_SALL4_ISOFORM_A | 3.91e-05 | 210 | 78 | 6 | MM958 | |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_UP | 5.47e-05 | 223 | 78 | 6 | M19693 | |
| Coexpression | WENG_POR_DOSAGE | 9.71e-05 | 30 | 78 | 3 | MM1199 | |
| Coexpression | MORI_PRE_BI_LYMPHOCYTE_UP | 1.01e-04 | 81 | 78 | 4 | M1395 | |
| Coexpression | KOBAYASHI_EGFR_SIGNALING_24HR_DN | 1.10e-04 | 253 | 78 | 6 | M16010 | |
| Coexpression | TABULA_MURIS_SENIS_TONGUE_BASAL_CELL_OF_EPIDERMIS_AGEING | 1.11e-04 | 158 | 78 | 5 | MM3851 | |
| Coexpression | WIEMANN_TELOMERE_SHORTENING_AND_CHRONIC_LIVER_DAMAGE_DN | 1.30e-04 | 6 | 78 | 2 | MM971 | |
| Coexpression | MORI_PRE_BI_LYMPHOCYTE_UP | 1.34e-04 | 87 | 78 | 4 | MM1136 | |
| CoexpressionAtlas | kidney single cell_e11.5_MetanephMesench_StemCellamp_top-relative-expression-ranked_100 | 5.11e-06 | 68 | 78 | 5 | gudmap_kidney single cell_e11.5_MetanephMesench_Scamp_100 | |
| CoexpressionAtlas | kidney single cell_e11.5_MetanephMesench_StemCellamp_top-relative-expression-ranked_200 | 1.39e-05 | 142 | 78 | 6 | gudmap_kidney single cell_e11.5_MetanephMesench_Scamp_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_B_emap-30374_k-means-cluster#2_top-relative-expression-ranked_200 | 3.41e-05 | 50 | 78 | 4 | gudmap_developingLowerUrinaryTract_P1_bladder_B_200_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_top-relative-expression-ranked_500 | 8.89e-05 | 388 | 78 | 8 | gudmap_developingLowerUrinaryTract_P1_bladder_500_J | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_k-means-cluster#5_top-relative-expression-ranked_200 | 1.22e-04 | 69 | 78 | 4 | gudmap_developingLowerUrinaryTract_P1_bladder_J_200_k5 | |
| ToppCell | normal_Lymph_Node-B_lymphocytes-GC_B_cells_in_the_DZ|normal_Lymph_Node / Location, Cell class and cell subclass | 4.89e-08 | 193 | 78 | 7 | 5ce93860bc60ce6ecfed3a3d985f84e28781eec1 | |
| ToppCell | (4)_B_Hypermutation|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 5.25e-08 | 195 | 78 | 7 | 54d2acaff6be6b5604591bdbd7d769ac3e74f223 | |
| ToppCell | Secretory|World / shred by cell class for bronchial biopsy | 1.22e-06 | 195 | 78 | 6 | 52f8281fe0df67cec3faa780a23ed6343ed5a6ba | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.25e-06 | 196 | 78 | 6 | b07db4a53ab9be9aad6fae5e45f9547db829d096 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_B-GC_B_(I)|lymph-node_spleen / Manually curated celltypes from each tissue | 1.25e-06 | 196 | 78 | 6 | 32d54c0b487f00c4f8bd765462e484da8a6625c9 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Goblet|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.25e-06 | 196 | 78 | 6 | c366f980cc04abfe1c0c14746c11810c812a42c0 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neurons_A-Branch_A1_(iMN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.29e-06 | 197 | 78 | 6 | fd43fc1cbf0c17b370397d73dddc572565a759c7 | |
| ToppCell | (4)_B_cells-(4)_B_Hypermutation|(4)_B_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 1.33e-06 | 198 | 78 | 6 | 8be724a49b4c911d68c3e82fb75e96722d0eaa03 | |
| ToppCell | metastatic_Lymph_Node-B_lymphocytes-GC_B_cells_in_the_DZ|B_lymphocytes / Location, Cell class and cell subclass | 1.33e-06 | 198 | 78 | 6 | 21c4762ca8591804cf77a23b64470e60d25c5357 | |
| ToppCell | normal_Lymph_Node-B_lymphocytes-GC_B_cells_in_the_DZ|B_lymphocytes / Location, Cell class and cell subclass | 1.33e-06 | 198 | 78 | 6 | 41e4bc7964a4895dd05bc62f0ef632ce9c89e34f | |
| ToppCell | B_cell_maturation-pre-B|B_cell_maturation / Lineage and Cell class | 1.37e-06 | 199 | 78 | 6 | 4bf6a656de04d92103cbe743cd07afd9d125c654 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW10-Neuronal|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 1.37e-06 | 199 | 78 | 6 | b2508bf591720830e8e3494b1337aab14539956d | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Fibroblasts|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.34e-06 | 157 | 78 | 5 | f086753b51860e23f1275bd75e8802d2a7d7b70a | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c12-MKI67-TYROBP|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.03e-05 | 164 | 78 | 5 | 4ef776d1bab4103d42d3a4f22cdfb49e8d2bc5a0 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.23e-05 | 170 | 78 | 5 | cb1ed6bd409ee1cf11be0d5e7cdcffe2ab220d38 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.23e-05 | 170 | 78 | 5 | da4fb1e186e9bec6bba0b25f2a0e68f9e11c6017 | |
| ToppCell | cellseq2-Epithelial-Epithelial_Glandular-Goblet-Goblet|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.26e-05 | 171 | 78 | 5 | 25c1979e972c959e1ce4c57804f976f53a247ad7 | |
| ToppCell | cellseq2-Epithelial-Epithelial_Glandular-Goblet|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.26e-05 | 171 | 78 | 5 | fe27bf581c75ef33c2848878e51ed16b275a4c8e | |
| ToppCell | Adult-Mesenchymal-pericyte_cell-D175|Adult / Lineage, Cell type, age group and donor | 1.33e-05 | 173 | 78 | 5 | fd6653d6be9ca6ac36798590694efe03cb758c67 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.49e-05 | 177 | 78 | 5 | 7ebdcedfe02da6d05bba3d625d8bd4c4ea96e4ad | |
| ToppCell | cellseq2-Mesenchymal-Myocytic-Myocytic_1-Pericyte|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.49e-05 | 177 | 78 | 5 | 68263456a3c93cd195b321b309ff59e156d732fe | |
| ToppCell | cellseq2-Mesenchymal-Myocytic-Myocytic_1|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.49e-05 | 177 | 78 | 5 | e415e448c37adc102d766235e9953dec32c021f1 | |
| ToppCell | wk_15-18-Epithelial-PNS-KCNIP4+_neuron|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.57e-05 | 179 | 78 | 5 | e20bfdfb6d5af8556eb66b81a19fbe4e3e28334a | |
| ToppCell | Lymphoid-Lymphoid-T_cells_(cycle)|Lymphoid / shred on cell class and cell subclass (v4) | 1.66e-05 | 181 | 78 | 5 | b6b41cd5d43543fe7a093033dae52a789199db0e | |
| ToppCell | Control-Neu_4|World / 5 Neutrophil clusters in COVID-19 patients | 1.80e-05 | 184 | 78 | 5 | ce7f044956613118ee2e9fb6af2455c3166cb414 | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Neuronal-neurons_B-Branch_B1_(eMN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.84e-05 | 185 | 78 | 5 | ef996f4cdbc3971c6c0460d13df64b075ab22154 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Neuronal-neurons_B-Branch_B2_(eMN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.84e-05 | 185 | 78 | 5 | 3d6711030ca4328357b06d5497cf98cdefcd7f4f | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Neuronal-neurons_B|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.84e-05 | 185 | 78 | 5 | d51342a3979bd728a80e04126059a3fd8a0dbe3b | |
| ToppCell | facs-Lung-EPCAM-24m-Hematologic-Proliferating_Immune|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-05 | 186 | 78 | 5 | 9ce3bd121869215a4e6114a310f9d2fb5adaef61 | |
| ToppCell | facs-Lung-EPCAM-24m-Hematologic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-05 | 186 | 78 | 5 | 18c40203463d4dd8558c04977d52e400a8268f90 | |
| ToppCell | facs-Lung-EPCAM-24m-Hematologic-leukocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-05 | 186 | 78 | 5 | a7fd35eabcfb534019dfe5a8a600bf2ec47c1ac2 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_proliferating|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.89e-05 | 186 | 78 | 5 | 5d527050cd554cc46c6d8dcb7981900725d79fc6 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_proliferating-Lymphatic_EC_proliferating_L.2.5.4.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.89e-05 | 186 | 78 | 5 | ee1c3e2adfa2900542200a218746b576c7ed10dc | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal-neurons_A-Branch_A1_(iMN)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.94e-05 | 187 | 78 | 5 | a748b3a59e398e0da019db3f16d38adb1960c29f | |
| ToppCell | wk_15-18-Epithelial-Airway_epithelial_progenitor-epi-stalk_early|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.04e-05 | 189 | 78 | 5 | a6c62b456982067ad4d224a2efa3919969000693 | |
| ToppCell | (02)_Cycling_Basal_(regeneration)-(1)_24hpi|(02)_Cycling_Basal_(regeneration) / shred by cell type and Timepoint | 2.04e-05 | 189 | 78 | 5 | 311f3aed469be3c8ff913dcc5a2442daa8446d55 | |
| ToppCell | (02)_Cycling_Basal_(regeneration)|World / shred by cell type and Timepoint | 2.10e-05 | 190 | 78 | 5 | 53f017a11ca5ebe9025558e12cedc409cab2e5aa | |
| ToppCell | wk_08-11-Epithelial-PNS-SST+_neuron|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.15e-05 | 191 | 78 | 5 | df2bef74a54f4c23c99bd3b93225fd36bcd90723 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c06-MKI67|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.15e-05 | 191 | 78 | 5 | b6cc0a9ced40ce5f80065d24d5bc20e3838a7682 | |
| ToppCell | P03-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.15e-05 | 191 | 78 | 5 | b978afe76754cc56e1672abca27be289bb56375b | |
| ToppCell | E17.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.15e-05 | 191 | 78 | 5 | f764cc21fef87ebad765011098f647ae1bdf6158 | |
| ToppCell | droplet-Thymus-nan-3m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.20e-05 | 192 | 78 | 5 | 041124dd5c24c1eb188d2560ba606422c0b215c5 | |
| ToppCell | droplet-Thymus-nan-3m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.20e-05 | 192 | 78 | 5 | d9e61b2722aa81e4f6e11865a04f2f1e75b794ab | |
| ToppCell | Non-neuronal-Dividing-Radial_Glia-Low_Quality-16|World / Primary Cells by Cluster | 2.20e-05 | 192 | 78 | 5 | 0d6413df15dfecdffc777fb02df3aaf0c30540b1 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_A-Branch_A1_(iMN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.20e-05 | 192 | 78 | 5 | fe9297cb65234d9f511bab1a5dbf2679d5a4cd15 | |
| ToppCell | Non-neuronal-Dividing-Radial_Glia-Low_Quality|World / Primary Cells by Cluster | 2.20e-05 | 192 | 78 | 5 | 5fa5b2f250ec5ad5a232c022266f0cd01ff4a753 | |
| ToppCell | P07-Endothelial-proliferative_endothelial_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.26e-05 | 193 | 78 | 5 | 1e95ef29357969ee385b4717c0b5a497390ac260 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.26e-05 | 193 | 78 | 5 | 605fc2a25ed6846fb283b2918cfed98df6039d6b | |
| ToppCell | P07-Endothelial-proliferative_endothelial_cell-proliferative_endothelial_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.26e-05 | 193 | 78 | 5 | 0f21fb8b35f89f4c1c8109d1a4d3d08a452f9edd | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP-PMP_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.32e-05 | 194 | 78 | 5 | af4bbb2deb5a3913eb58990690fc3c62fbc3708c | |
| ToppCell | E15.5-Mesenchymal-developing_mesenchymal_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.32e-05 | 194 | 78 | 5 | d840c1949c328779426c9172e02da09e968f0567 | |
| ToppCell | E12.5-Mesenchymal-developing_mesenchymal_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.37e-05 | 195 | 78 | 5 | 97b2ff072cc830a4a2cb217f5a215ca6cad505ec | |
| ToppCell | metastatic_Lymph_Node-B_lymphocytes-GC_B_cells_in_the_DZ|metastatic_Lymph_Node / Location, Cell class and cell subclass | 2.37e-05 | 195 | 78 | 5 | 3c5b7cce4a1c4b28fa3b657cce4148669a59e55e | |
| ToppCell | wk_08-11-Epithelial-PNS-TM4SF4+_PENK+_neuron|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.43e-05 | 196 | 78 | 5 | afa3a2f5f3a51d1830c6f95f97a4b3e13ed42512 | |
| ToppCell | E12.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.43e-05 | 196 | 78 | 5 | 62b2de1d38a99ab23211bf51595845f8a1fdb7d2 | |
| ToppCell | erythropoietic-Erythrocyte|World / Lineage and Cell class | 2.43e-05 | 196 | 78 | 5 | 1642d9340f621cd55987ef8154b48aa306f0f0c8 | |
| ToppCell | 10x5'-bone_marrow-Hematopoietic_progenitors|bone_marrow / Manually curated celltypes from each tissue | 2.43e-05 | 196 | 78 | 5 | 4143dab6dce3c88c9b002c64699ab453149990e7 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal-neurons_B|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.49e-05 | 197 | 78 | 5 | a1ae1aa797762a3768e14434c7e5cd19c595ecb3 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_Prolif-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.49e-05 | 197 | 78 | 5 | 196eaecef7003ed83f323c1f157c6a3594650097 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP-PMP_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.49e-05 | 197 | 78 | 5 | 29b0a5927f80455eef7b793feabef69fba1a3df1 | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Neuronal-neurons_A|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.49e-05 | 197 | 78 | 5 | a07e1a9b95c9f8a09452cbfe5a9f06648f66e29e | |
| ToppCell | myeloid-CD34+_Monoblast|myeloid / Lineage and Cell class | 2.55e-05 | 198 | 78 | 5 | e26b98a8380e693110a97d8e5a353998f8d67c6d | |
| ToppCell | cycling_basal_cell|World / shred by cell class for bronchial biopsy | 2.55e-05 | 198 | 78 | 5 | d5306121a75c5eb37d62c353799a98e6ba5ab63f | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Neuronal-ventral_progenitors_and_neurons_2|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 2.55e-05 | 198 | 78 | 5 | b73b9feb82997b654718aa27f33ca7b454214802 | |
| ToppCell | B_cell_maturation-CD34+_pro-B|B_cell_maturation / Lineage and Cell class | 2.55e-05 | 198 | 78 | 5 | 5737606e5e3dc56f11fdf70166caf4ba4a81bc9d | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal-neurons_A|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.55e-05 | 198 | 78 | 5 | 50504a3871f76d6a5b439a56450d7770f4501eb0 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Neuronal-neurons_A-Branch_A1_(iMN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.55e-05 | 198 | 78 | 5 | dac7b68bb8f1c4d8aa7fdfada61f79956866e874 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Suprabasal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.55e-05 | 198 | 78 | 5 | 19d8ff3a4f911b13ecc34844202925475ad4d2ab | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW10-Neuronal-Neurons|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 2.61e-05 | 199 | 78 | 5 | 0c5a5fbb174a013be10961f0db65c65c797ab4af | |
| ToppCell | 3'-Child04-06-SmallIntestine-Hematopoietic-B_cells-Cycling_B_cell|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.61e-05 | 199 | 78 | 5 | 8b7f84a1e385c6a9bd45a5d41f75e30819dbe32d | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.61e-05 | 199 | 78 | 5 | 5f350d9c7da9ac111bf22623dd4fed7f7983c9fc | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.61e-05 | 199 | 78 | 5 | 1e693d7bb481bf03a943b460a69787229625d7b1 | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_B-B_lineage-pre_pro_B_progenitor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.61e-05 | 199 | 78 | 5 | 8e7f9312dec1e3a92b6a0ccc7baa2d46e89c11f3 | |
| ToppCell | remission-T/NK_proliferative|World / disease stage, cell group and cell class | 2.61e-05 | 199 | 78 | 5 | f305f3a454b7d2170429bad087480ccccca19acd | |
| ToppCell | COVID-19_Mild-T/NK_proliferative|COVID-19_Mild / Disease condition and Cell class | 2.61e-05 | 199 | 78 | 5 | 9f9a88d2b099646c1e1a7ee3f8d39cb1a2498ad7 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.61e-05 | 199 | 78 | 5 | 0da69ca107e826740f0ba3159012aa25e1b9da6a | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW16-Neuronal-Neurons|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 2.61e-05 | 199 | 78 | 5 | ae575ed7582f2a4218f6cbcbf5f7f0ce7a5bc26b | |
| ToppCell | COVID-19_Convalescent-T/NK_proliferative|COVID-19_Convalescent / Disease condition and Cell class | 2.61e-05 | 199 | 78 | 5 | c608d953b852b67a4e36bd63d45f0deec3eefbd9 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW26-Neuronal|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 2.61e-05 | 199 | 78 | 5 | a255484ba77bd2741a541da278efc8cf4abbe570 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW16-Neuronal|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 2.68e-05 | 200 | 78 | 5 | 1decf1d2cba5ebfd3e5cd4bcd637db8f193033ce | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-T/NK_proliferative|COVID-19_Mild / Disease, condition lineage and cell class | 2.68e-05 | 200 | 78 | 5 | 6126a3bbafe2110fba0c1c4493035df4e8193d22 | |
| ToppCell | wk_08-11|World / Celltypes from embryonic and fetal-stage human lung | 2.68e-05 | 200 | 78 | 5 | aa35c33762880a5e030a7e691c425524f7dbff8a | |
| ToppCell | (5)_Epi_dividing|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 2.68e-05 | 200 | 78 | 5 | 948c55aa1c25f8a69b1bd3ef53fd32aa222f592c | |
| ToppCell | 356C-Myeloid-Dendritic-cDC_proliferating_1|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 2.68e-05 | 200 | 78 | 5 | 548a0f486ab8745da107f2815914dbf873a6e3c8 | |
| ToppCell | myeloid-pro-cDC|myeloid / Lineage and Cell class | 2.68e-05 | 200 | 78 | 5 | 4aa2308eeb94e0bdff4e02eb9e45ba8837ae14bf | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal-Cortical_neuron|5w / Sample Type, Dataset, Time_group, and Cell type. | 2.68e-05 | 200 | 78 | 5 | 085060d148158f7d9e938b6c4a3700ccbb3bca15 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09-Stem_cells-Neuroepithelial_cell|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 2.68e-05 | 200 | 78 | 5 | c88d8e67647c90d1fa2569516865a9fd766eaf1c | |
| ToppCell | (5)_Epithelial_cells-(5)_Epi_dividing|(5)_Epithelial_cells / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 2.68e-05 | 200 | 78 | 5 | b46b2064362efc64edf19ab2b21bc89047c9d943 | |
| ToppCell | Severe-Developping_Plasmablast|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.68e-05 | 200 | 78 | 5 | 6d0cd00e52568d23597cc2a4059bd967d7d2dab5 | |
| ToppCell | NS-critical-LOC-Lymphoid-Treg|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.68e-05 | 200 | 78 | 5 | d51e5c8c154b073caaf0cc09a3a3c0aafd57e44b | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.68e-05 | 200 | 78 | 5 | 43571c9284d4e41402a2d1eefc1efe2ce8476d4a | |
| ToppCell | tumor_Lymph_Node_/_Brain-T/NK_cells-Undetermined|T/NK_cells / Location, Cell class and cell subclass | 2.68e-05 | 200 | 78 | 5 | cfec2f712b870797fab3b0770f16feaafd37e8d5 | |
| ToppCell | 10x5'v1-week_17-19-Lymphocytic_B-B_lineage|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.68e-05 | 200 | 78 | 5 | c28d4ca51d2e2a3a22784ee251975f16a55b0297 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10-Neuronal|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 2.68e-05 | 200 | 78 | 5 | 04699d1149a143b96d6f292c0d70c4d3e6dfc611 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09-Stem_cells|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 2.68e-05 | 200 | 78 | 5 | 28935053cd6918cd2e9f3e7691f8522216585cb6 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.68e-05 | 200 | 78 | 5 | 38665128b54f4a81b53c961427aed67bf4e2510b | |
| ToppCell | 10x5'v1-week_17-19-Lymphocytic_B|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.68e-05 | 200 | 78 | 5 | 364f09eb9ae4913f5c80a29e943e1c0b2ffd5f93 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal|5w / Sample Type, Dataset, Time_group, and Cell type. | 2.68e-05 | 200 | 78 | 5 | 9b5753726c17dda98d7384a60f26a5eaf4f6c4d6 | |
| ToppCell | B_cell_maturation-pre-B|World / Lineage and Cell class | 2.68e-05 | 200 | 78 | 5 | acb9ad7e3c05ec38e9700fb27b6eed8eaa565689 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_Prolif|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.68e-05 | 200 | 78 | 5 | cab374b7c56310329951c2ca44a7179ffa895b7d | |
| Computational | Cytochrome P450. | 3.13e-05 | 14 | 49 | 3 | MODULE_106 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 5.89e-05 | 47 | 49 | 4 | GAVISH_3CA_METAPROGRAM_B_CELLS_CELL_CYCLE | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 5.89e-05 | 47 | 49 | 4 | GAVISH_3CA_METAPROGRAM_MACROPHAGES_CELL_CYCLE | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 6.94e-05 | 49 | 49 | 4 | GAVISH_3CA_METAPROGRAM_CD4_T_CELLS_CELL_CYCLE | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 6.94e-05 | 49 | 49 | 4 | GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CELL_CYCLE | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 7.52e-05 | 50 | 49 | 4 | GAVISH_3CA_METAPROGRAM_EPITHELIAL_CELL_CYCLE | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 7.52e-05 | 50 | 49 | 4 | GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_CELL_CYCLE | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.42e-03 | 49 | 49 | 3 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CELL_CYCLE | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.50e-03 | 50 | 49 | 3 | GAVISH_3CA_MALIGNANT_METAPROGRAM_3_CELL_CYLCE_HMG_RICH | |
| Drug | 2-demethylcolchicine | 1.29e-13 | 32 | 78 | 8 | CID000023757 | |
| Drug | colchiceine | 5.90e-13 | 38 | 78 | 8 | CID000010156 | |
| Drug | AC1Q6P06 | 1.92e-12 | 25 | 78 | 7 | CID000160263 | |
| Drug | amiprophosmethyl | 1.03e-11 | 31 | 78 | 7 | CID000100524 | |
| Drug | 2,3,4-tabp | 1.28e-10 | 23 | 78 | 6 | CID000125548 | |
| Drug | NSC355636 | 1.28e-10 | 23 | 78 | 6 | CID000100176 | |
| Drug | IKP104 | 1.28e-10 | 23 | 78 | 6 | CID000130739 | |
| Drug | 2,3,4-TCB | 1.28e-10 | 23 | 78 | 6 | CID000129239 | |
| Drug | N-acetylcolchinol | 1.28e-10 | 23 | 78 | 6 | CID000097865 | |
| Drug | parbendazole | 1.70e-10 | 24 | 78 | 6 | CID000026596 | |
| Drug | tropolone methyl ether | 1.70e-10 | 24 | 78 | 6 | CID000016546 | |
| Drug | AC1L4TG7 | 1.70e-10 | 24 | 78 | 6 | CID000163705 | |
| Drug | NSC-36768 | 1.70e-10 | 24 | 78 | 6 | CID000165441 | |
| Drug | deacetamidocolchicine | 1.70e-10 | 24 | 78 | 6 | CID000014995 | |
| Drug | colchicide | 1.70e-10 | 24 | 78 | 6 | CID000120712 | |
| Drug | allocolchicine | 2.23e-10 | 25 | 78 | 6 | CID000196989 | |
| Drug | 55623-37-5 | 2.23e-10 | 25 | 78 | 6 | CID006438440 | |
| Drug | MDL 27048 | 2.23e-10 | 25 | 78 | 6 | CID006439188 | |
| Drug | NBD-colcemid | 2.23e-10 | 25 | 78 | 6 | CID000130594 | |
| Drug | 2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone | 2.23e-10 | 25 | 78 | 6 | CID000043264 | |
| Drug | NSC527981 | 2.90e-10 | 26 | 78 | 6 | CID000352796 | |
| Drug | NSC332029 | 2.90e-10 | 26 | 78 | 6 | CID000100073 | |
| Drug | pironetin | 2.90e-10 | 26 | 78 | 6 | CID006438891 | |
| Drug | NSC654663 | 3.22e-10 | 49 | 78 | 7 | CID000375252 | |
| Drug | bis-ANS | 3.45e-10 | 81 | 78 | 8 | CID000123808 | |
| Drug | AC1L1J4H | 3.71e-10 | 27 | 78 | 6 | CID000004862 | |
| Drug | dinitroanilines | 3.71e-10 | 27 | 78 | 6 | CID000136400 | |
| Drug | NSC292222 | 3.71e-10 | 27 | 78 | 6 | CID000099957 | |
| Drug | NSC D-669356 | 3.71e-10 | 27 | 78 | 6 | CID000178028 | |
| Drug | NSC 370147 | 4.71e-10 | 28 | 78 | 6 | CID000182762 | |
| Drug | NSC72302 | 4.71e-10 | 28 | 78 | 6 | CID000118078 | |
| Drug | oxibendazole | 5.93e-10 | 29 | 78 | 6 | CID000004622 | |
| Drug | Aids106696 | 5.93e-10 | 29 | 78 | 6 | CID006475933 | |
| Drug | NSC 89199 | 6.55e-10 | 54 | 78 | 7 | CID000003268 | |
| Drug | AC1NBBHE | 7.39e-10 | 30 | 78 | 6 | CID004490620 | |
| Drug | eleutherobin | 7.39e-10 | 30 | 78 | 6 | CID006918335 | |
| Drug | azatoxin | 7.39e-10 | 30 | 78 | 6 | CID000125383 | |
| Drug | NSC617668 | 7.39e-10 | 30 | 78 | 6 | CID000357989 | |
| Drug | citostal | 7.39e-10 | 30 | 78 | 6 | CID000018991 | |
| Drug | thiocolchicine | 7.39e-10 | 30 | 78 | 6 | CID000017648 | |
| Drug | NSC609395 | 9.14e-10 | 31 | 78 | 6 | CID005488798 | |
| Drug | 3,4-dimethylhexane-2,5-dione | 9.14e-10 | 31 | 78 | 6 | CID000032851 | |
| Drug | tropone | 9.14e-10 | 31 | 78 | 6 | CID000010881 | |
| Drug | AC1L3V8I | 9.14e-10 | 31 | 78 | 6 | CID000122777 | |
| Drug | NSC332598 | 9.14e-10 | 31 | 78 | 6 | CID000615942 | |
| Drug | N,N'-ethylenebis(iodoacetamide | 9.14e-10 | 31 | 78 | 6 | CID000023678 | |
| Drug | benzimidazole | 1.06e-09 | 93 | 78 | 8 | CID000005798 | |
| Drug | AC1L1G95 | 1.12e-09 | 32 | 78 | 6 | CID000003583 | |
| Drug | NSC153858 | 1.12e-09 | 32 | 78 | 6 | CID000547450 | |
| Drug | mebendazole | 1.37e-09 | 33 | 78 | 6 | CID000004030 | |
| Drug | CA4P | 1.37e-09 | 33 | 78 | 6 | CID000370232 | |
| Drug | taltobulin | 1.37e-09 | 33 | 78 | 6 | CID006918637 | |
| Drug | NSC376450 | 1.66e-09 | 34 | 78 | 6 | CID000005605 | |
| Drug | 2-phenyl-4-quinolone | 1.66e-09 | 34 | 78 | 6 | CID000161091 | |
| Drug | discodermolide | 1.99e-09 | 35 | 78 | 6 | CID000643668 | |
| Drug | AC1O5Y0F | 2.84e-09 | 37 | 78 | 6 | CID006442852 | |
| Drug | DTAF | 2.84e-09 | 37 | 78 | 6 | CID000123934 | |
| Drug | albendazole | 2.84e-09 | 37 | 78 | 6 | CID000002082 | |
| Drug | baccatin III | 2.84e-09 | 37 | 78 | 6 | CID000065366 | |
| Drug | gnoscopine | 3.36e-09 | 38 | 78 | 6 | CID000004544 | |
| Drug | laulimalide | 3.36e-09 | 38 | 78 | 6 | CID006918457 | |
| Drug | erianin | 3.96e-09 | 39 | 78 | 6 | CID000356759 | |
| Drug | Dolastatin 10 | 3.96e-09 | 39 | 78 | 6 | CID000100208 | |
| Drug | AC1L8GZ1 | 4.65e-09 | 40 | 78 | 6 | CID000381235 | |
| Drug | lumicolchicine | 5.43e-09 | 41 | 78 | 6 | CID000072624 | |
| Drug | valproate | TUBB3 TUBB4A TUBB4B CYP2B6 CACNA2D4 CYP2C19 CYP2C9 KCNQ4 TUBB CACNA1I TUBB2B CPS1 | 6.53e-09 | 381 | 78 | 12 | CID000003121 |
| Drug | AC1L9CY0 | 7.33e-09 | 43 | 78 | 6 | CID000396644 | |
| Drug | Stylophorin | 7.33e-09 | 43 | 78 | 6 | CID000010147 | |
| Drug | imipramine | TUBB3 TUBB4A TUBB4B CYP2C19 CYP2C9 TUBB SRF TUBB2B TUBB2A PLCE1 | 7.72e-09 | 235 | 78 | 10 | CID000003696 |
| Drug | 2-methoxyestradiol | TUBB3 TUBB4A TUBB4B UGT2A3 TUBB ARFGEF2 ARFGEF1 TUBB2B TUBB2A TBX1 | 8.04e-09 | 236 | 78 | 10 | CID000001573 |
| Drug | bromocolchicine | 8.08e-09 | 21 | 78 | 5 | CID000161518 | |
| Drug | colchifoline | 8.08e-09 | 21 | 78 | 5 | CID000100132 | |
| Drug | Ustiloxin A | 8.08e-09 | 21 | 78 | 5 | CID000164454 | |
| Drug | SRI-3072 | 8.08e-09 | 21 | 78 | 5 | CID000493469 | |
| Drug | methyl ether | 9.73e-09 | 45 | 78 | 6 | CID000008254 | |
| Drug | 3,4,5-trimethoxyacetophenone | 1.04e-08 | 22 | 78 | 5 | CID000014345 | |
| Drug | AC1L1GIQ | 1.04e-08 | 22 | 78 | 5 | CID000003700 | |
| Drug | 2,4-dichlorobenzyl thiocyanate | 1.04e-08 | 22 | 78 | 5 | CID000098538 | |
| Drug | SureCN13401588 | 1.04e-08 | 22 | 78 | 5 | CID009897422 | |
| Drug | N-methyldemecolcine | 1.04e-08 | 22 | 78 | 5 | CID000023759 | |
| Drug | NSC-339672 | 1.04e-08 | 22 | 78 | 5 | CID000433930 | |
| Drug | 3,4,5-trimethoxybenzaldehyde | 1.33e-08 | 23 | 78 | 5 | CID000006858 | |
| Drug | AC1L2P05 | 1.33e-08 | 23 | 78 | 5 | CID000125688 | |
| Drug | NSC-373301 | 1.33e-08 | 23 | 78 | 5 | CID000341375 | |
| Drug | fluorescein-colchicine | 1.33e-08 | 23 | 78 | 5 | CID003035871 | |
| Drug | 3-demethylthiocolchicine | 1.33e-08 | 23 | 78 | 5 | CID000084076 | |
| Drug | 7-epi-cephalomannine | 1.67e-08 | 24 | 78 | 5 | CID000330401 | |
| Drug | NABV | 1.67e-08 | 24 | 78 | 5 | CID000175959 | |
| Drug | moscatilin | 1.67e-08 | 24 | 78 | 5 | CID000176096 | |
| Drug | GaCl3 | 1.87e-08 | 50 | 78 | 6 | CID000026010 | |
| Drug | Z)-combretastatin A-4 | 1.87e-08 | 50 | 78 | 6 | CID000072686 | |
| Drug | mpMap | 2.09e-08 | 25 | 78 | 5 | CID000100806 | |
| Drug | 1069C85 | 2.09e-08 | 25 | 78 | 5 | CID006918099 | |
| Drug | 2,4,3',5'-tetramethoxystilbene | 2.09e-08 | 25 | 78 | 5 | ctd:C440850 | |
| Drug | CA1P | 2.09e-08 | 25 | 78 | 5 | CID006918545 | |
| Drug | peloruside A | 2.09e-08 | 25 | 78 | 5 | CID006918506 | |
| Drug | NSC142227 | 2.09e-08 | 25 | 78 | 5 | CID000073427 | |
| Drug | combretastatin | 2.12e-08 | 51 | 78 | 6 | CID000100154 | |
| Drug | TK-B | 2.12e-08 | 51 | 78 | 6 | CID000009074 | |
| Drug | magnesium sulfate | 2.39e-08 | 52 | 78 | 6 | CID000024083 | |
| Disease | facial paralysis (implicated_via_orthology) | 5.39e-14 | 10 | 77 | 6 | DOID:13934 (implicated_via_orthology) | |
| Disease | complex cortical dysplasia with other brain malformations 7 (implicated_via_orthology) | 5.39e-14 | 10 | 77 | 6 | DOID:0090132 (implicated_via_orthology) | |
| Disease | ptosis (implicated_via_orthology) | 5.39e-14 | 10 | 77 | 6 | DOID:0060260 (implicated_via_orthology) | |
| Disease | tubulinopathy (implicated_via_orthology) | 5.39e-14 | 10 | 77 | 6 | DOID:0112227 (implicated_via_orthology) | |
| Disease | cerebellar ataxia, mental retardation and dysequlibrium syndrome (implicated_via_orthology) | 2.36e-13 | 12 | 77 | 6 | DOID:0050997 (implicated_via_orthology) | |
| Disease | hypokalemic periodic paralysis (implicated_via_orthology) | 9.48e-07 | 8 | 77 | 3 | DOID:14452 (implicated_via_orthology) | |
| Disease | chromosome 22q11.2 deletion syndrome, distal (implicated_via_orthology) | 6.09e-06 | 14 | 77 | 3 | DOID:0060413 (implicated_via_orthology) | |
| Disease | X-21258 measurement | 2.01e-05 | 3 | 77 | 2 | EFO_0800802 | |
| Disease | Congenital Fibrosis of the Extraocular Muscles | 2.01e-05 | 3 | 77 | 2 | C1302995 | |
| Disease | congenital heart disease (is_marker_for) | 4.02e-05 | 4 | 77 | 2 | DOID:1682 (is_marker_for) | |
| Disease | Drug-Induced Liver Disease | 9.03e-05 | 404 | 77 | 7 | C0860207 | |
| Disease | Drug-Induced Acute Liver Injury | 9.03e-05 | 404 | 77 | 7 | C3658290 | |
| Disease | Chemical and Drug Induced Liver Injury | 9.03e-05 | 404 | 77 | 7 | C4277682 | |
| Disease | Hepatitis, Drug-Induced | 9.03e-05 | 404 | 77 | 7 | C1262760 | |
| Disease | Hepatitis, Toxic | 9.03e-05 | 404 | 77 | 7 | C0019193 | |
| Disease | Chemically-Induced Liver Toxicity | 9.03e-05 | 404 | 77 | 7 | C4279912 | |
| Disease | handedness | 1.74e-04 | 106 | 77 | 4 | EFO_0009902 | |
| Disease | response to clopidogrel, response to acetylsalicylate, major adverse cardiovascular event measurement | 2.39e-04 | 9 | 77 | 2 | EFO_0020863, GO_1903492, GO_1903493 | |
| Disease | X-11308 measurement | 3.64e-04 | 11 | 77 | 2 | EFO_0800693 | |
| Disease | gastric adenocarcinoma (is_implicated_in) | 3.64e-04 | 11 | 77 | 2 | DOID:3717 (is_implicated_in) | |
| Disease | thymol sulfate measurement | 4.36e-04 | 12 | 77 | 2 | EFO_0021170 | |
| Disease | tetralogy of Fallot (is_implicated_in) | 5.15e-04 | 13 | 77 | 2 | DOID:6419 (is_implicated_in) | |
| Disease | ventricular septal defect (is_implicated_in) | 5.99e-04 | 14 | 77 | 2 | DOID:1657 (is_implicated_in) | |
| Disease | dental caries, dentures | 8.25e-04 | 70 | 77 | 3 | EFO_0003819, EFO_0010078 | |
| Disease | dentures | 8.25e-04 | 70 | 77 | 3 | EFO_0010078 | |
| Disease | hypertension | 1.26e-03 | 307 | 77 | 5 | EFO_0000537 | |
| Disease | Left Ventricle Remodeling | 1.37e-03 | 21 | 77 | 2 | C0600520 | |
| Disease | Ventricular Remodeling | 1.37e-03 | 21 | 77 | 2 | C0600519 | |
| Disease | Nephritis, Tubulointerstitial | 1.37e-03 | 21 | 77 | 2 | C0041349 | |
| Disease | fat intake measurement | 1.50e-03 | 22 | 77 | 2 | EFO_0010809 | |
| Disease | progression free survival, ovarian serous carcinoma | 1.50e-03 | 22 | 77 | 2 | EFO_0004920, EFO_1001516 | |
| Disease | Renal glomerular disease | 1.64e-03 | 23 | 77 | 2 | C0268731 | |
| Disease | Glomerulopathy Assessment | 1.64e-03 | 23 | 77 | 2 | C4521256 | |
| Disease | platelet reactivity measurement, response to clopidogrel | 1.64e-03 | 23 | 77 | 2 | EFO_0004985, GO_1903493 | |
| Disease | insulin sensitivity measurement | 1.64e-03 | 23 | 77 | 2 | EFO_0004471 | |
| Disease | female reproductive system disease | 1.64e-03 | 23 | 77 | 2 | EFO_0009549 | |
| Disease | Varicose veins | 1.65e-03 | 193 | 77 | 4 | HP_0002619 | |
| Disease | Nephritis, Interstitial | 1.79e-03 | 24 | 77 | 2 | C0027707 | |
| Disease | congenital heart disease (is_implicated_in) | 1.79e-03 | 24 | 77 | 2 | DOID:1682 (is_implicated_in) | |
| Disease | aggressive behavior | 1.94e-03 | 25 | 77 | 2 | EFO_0003015 | |
| Disease | response to interferon | 1.94e-03 | 25 | 77 | 2 | EFO_0007859 | |
| Disease | S-warfarin to R-warfarin ratio measurement | 1.99e-03 | 95 | 77 | 3 | EFO_0803331 | |
| Disease | macular telangiectasia type 2 | 2.10e-03 | 26 | 77 | 2 | EFO_1002009 | |
| Disease | ergothioneine measurement | 2.10e-03 | 26 | 77 | 2 | EFO_0021163 | |
| Disease | blood rubidium measurement | 2.10e-03 | 26 | 77 | 2 | EFO_0021529 | |
| Disease | Colorectal Carcinoma | 2.38e-03 | 702 | 77 | 7 | C0009402 | |
| Disease | tuberculosis (is_implicated_in) | 2.43e-03 | 28 | 77 | 2 | DOID:399 (is_implicated_in) | |
| Disease | Cone-Rod Dystrophy 2 | 2.61e-03 | 29 | 77 | 2 | C3489532 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RFSVTTMRDFGMGKR | 126 | P20813 | |
| MMTLGRLRGFEGKLT | 336 | Q86VW2 | |
| AKGRVVNISSMLGRM | 186 | Q02338 | |
| RTRGLTVMFEIMKTY | 1401 | Q9Y6D6 | |
| DVRTRGLTVMFEIMK | 1346 | Q9Y6D5 | |
| LGIAFMGMSRTVVLD | 3986 | Q86UQ4 | |
| ARFIMEAGVKLGMRS | 31 | Q8N1B3 | |
| LTSMVLFMKRIDIAG | 426 | Q7L7V1 | |
| RREMTAKGSTGMEIL | 56 | Q9UPW5 | |
| KVIFSLSRVGSAMAM | 1071 | Q96F81 | |
| KSMSTVIRMPDGGFR | 581 | Q16720 | |
| GSIMAVRIVRDKMTG | 311 | P42696 | |
| MSRIEKMSILGVRSF | 1 | Q92878 | |
| GGRRVSKALMASMAR | 201 | Q9UNF1 | |
| RSTEMILTKQGRRMF | 91 | Q8IWI9 | |
| GRMMFVGTSVGTIRA | 606 | Q96MR6 | |
| TVAMLRGEMFVFKGR | 376 | P51511 | |
| FMATRIGTFRMDLGI | 101 | A9Z1Z3 | |
| SSRMGIKDRIRMGSS | 431 | P56696 | |
| RAVGKSLAMEMVLTG | 181 | P30084 | |
| GQIMFLTGMVDKRTL | 221 | Q8IYD1 | |
| MMLSTEGREGFVVKV | 1 | P55795 | |
| TKGRMVMSRGGELVM | 1101 | Q9H6R4 | |
| MKRRAGLGGSMRSVV | 1 | Q96JK2 | |
| VGMTEMTRTFGLELL | 236 | Q7Z3U7 | |
| GPMFSGKSTELMRRV | 26 | P04183 | |
| ISSFTPKMQGRRMGT | 1376 | Q86UR5 | |
| RGSGEMMTRSPVKVT | 316 | O60313 | |
| SMKSVGEVMAIGRTF | 791 | P31327 | |
| RKAGSFEMIMLGRLL | 116 | Q9BYW1 | |
| RMVASMSKRRCGVGV | 346 | Q9Y2M5 | |
| FSLMTLRNFGMGKRS | 126 | P33261 | |
| VDVSGSMKGLRMTIA | 296 | Q7Z3S7 | |
| LFSKVERLTQRMAGM | 716 | Q8IVF7 | |
| ALGSRKSSVMSLGRM | 946 | Q9P0X4 | |
| IKRFMLEVTEMFSIG | 461 | A8TX70 | |
| TMTRVQAKGMGILLE | 386 | Q16880 | |
| DTKRIEVMVGMGYTR | 331 | Q96L34 | |
| VSGTKSMLLERMRGG | 191 | Q6ZN01 | |
| KTMRIRMTDGRTLVG | 51 | Q9BRA0 | |
| FSLMTLRNFGMGKRS | 126 | P11712 | |
| VEFILRSMSRSTGFM | 61 | Q6UWT4 | |
| TFGGSTGRMMLKERQ | 486 | Q9P212 | |
| GMKALVTLSSGDMRR | 201 | P40937 | |
| GAIIVVVMRKMSGRY | 146 | Q86YL7 | |
| FERRGFTLVGMKMLQ | 61 | O00746 | |
| TSKDFLMGGRRMTAV | 41 | Q8N695 | |
| LTVAAIFRGRMSMKE | 311 | Q13885 | |
| EEMSRVLMGGTLGRS | 556 | Q9H6T0 | |
| MRGRKSGGSMVVAVI | 3076 | Q6ZRS2 | |
| RGLKRSLSEMEIGMV | 96 | P11831 | |
| KIGRLRMLAGSSVMS | 621 | Q7L0J3 | |
| RTKGDLMIDSRIVMG | 216 | Q8NCG5 | |
| TRMALRKTGQYSGML | 306 | Q6KCM7 | |
| LGTEMIVTKAGRRMF | 81 | O75333 | |
| MLMITRRGVLFVTKG | 3086 | Q96RL7 | |
| LNIRVGGTGMFTVRM | 446 | P07911 | |
| TGQTVLLTLMRRGMK | 451 | O75970 | |
| LGTEMVITKSGRRMF | 121 | Q13207 | |
| LTVAAVFRGRMSMKE | 311 | P04350 | |
| LTVAAIFRGRMSMKE | 311 | Q9BVA1 | |
| LTVAAVFRGRMSMKE | 311 | P68371 | |
| LTVAAVFRGRMSMKE | 311 | P07437 | |
| SKVMKGRMGSSLVIE | 756 | Q9NTJ3 | |
| LTVATVFRGRMSMKE | 311 | Q13509 | |
| SVGTEMIITKAGRRM | 106 | O95947 | |
| VKMLGASRTGISNMR | 21 | A6NIE6 | |
| SVKELGTVMRMLGQT | 36 | P02585 | |
| MKTSDTIIREGTLMG | 171 | Q9GZM5 | |
| FLTGIGLDTTIMMRS | 236 | Q9NNW7 | |
| FLEDLTKMGGAMRSV | 251 | Q6ZT12 | |
| TKMGGAMRSVLTQVL | 256 | Q6ZT12 | |
| MTGLTDRMTFLERVK | 196 | Q6UWM9 | |
| IGREVATRMQSFGMK | 156 | O43175 | |
| LGTEMIITKSGRRMF | 116 | Q9UMR3 | |
| LGTEMIVTKAGRRMF | 126 | O43435 | |
| MEKMSRVTTALGGSV | 1 | Q96S15 | |
| ISMTEGMEAFLRGRQ | 511 | Q69YN4 | |
| LMTASGTHGRIKFMV | 86 | Q9H354 | |
| VISMRDGKLTLMFRV | 201 | P48549 |